woman to local anesthetic drug so the dose of local anesthetic is often reduced up to two-third. [7] Pain relief prolongation by many adjuvants such as morphine, fentanyl, ketamine, and midazolam, were examined and investigated by different investigators. However, each of them has its side effects and limitations, and the necessity for alternative manners and medications always exist. [8] [9] [10] In the present study, we compared the effect of 1 and 2 mg midazolam added to hyperbaric bupivacaine on the duration of sensory and motor block and intraoperative hemodynamic changes for cesarian section (CS) under spinal anesthesia.
MaterIals and Methods

Study design and patients recruitment
Following obtaining Institutional Ethical Clearance from the Local Health Ethics Committee from the General Duhok Directorate of Health and written informed agreement from the patients, 90 pregnant women (Range: 18-40 years) were underwent elective CS were recruited into the study from April 15, 2015 to October 1, 2015. For this regard, they were underwent spinal anesthesia for the surgery and study purpose. Patients refused to participate, patients with known allergy to local anesthetic drugs, chronic hypertension, and patients were taking antihypertensive drugs during surgery time were excluded from the study.
In a comparative controlled clinical trial in the theaters of Maternity Teaching Hospital in Duhok, Iraq, patients with the American Society of Anesthesiology Classifications (ASA physical status Ι and ΙΙ) were randomly classified into following three groups: Group A (n = 30), the patients in this group received intrathecal bupivacaine 12.5 mg (2.5 ml) + 0.4 ml of normal saline total volume was 2.9 ml; Group B (n = 30), this group received intrathecal bupivacaine 12.5 mg (2.5 ml) +1 mg (0.4 ml) midazolam total volume was 2.9 ml; and Group C (n = 30) received intrathecal bupivacaine 12.5 mg (2.5 ml) +2 mg (0.4 ml) midazolam total volume was 2.9 ml. The full required information and the explanation regarding the study and procedure were presented to the patients in the preoperative checkup and visit.
Clinical procedure
At entrance to the operation room, intravenous access was initiated with an 18G intravenous cannula in a wide caliber vein at the forearm, and co-loading had been done with prewarmed Ringer's lactate solution 15 ml/kg body weight infused during 15 min.
Through using precise aseptic precautions, a 25G pencil point spinal needle was established into L3-L4 or L4-L5 intervertebral space in midline approach in sitting position, after verifying free flow of cerebrospinal fluid, predetermined 2.9 ml of drug solution was injected. When the injection finished, a small aseptic dressing was utilized and the patients placed in a supine position with a pillow beneath the neck and head quickly after introducing of subarachnoid medications. Oxygen (2 L/min) was administered during the procedure using nasal cannula. Fluid therapy was done intraoperatively regarding to the patient body weight, intraoperative losses, and vital signs.
Measurement criteria
Datasheet arrangement for preoperative blood pressure and pulse rate (PR) and intraoperative blood pressure and PR every 5-min interval until the end of operation and postoperative to determine the duration of sensory block was assessed by time to first request for analgesia, and duration of motor block was assessed by time to first movement of the lower limbs at the level of hip joints. The data were collected to compare between the duration of sensory and motor blocks among the 3 groups and comparing the intraoperative hemodynamic changes among them.
Moreover, the following parameters were assessed for the study purpose: (a) assessment of duration of sensory block; (b) assessment of duration of motor block; (c) assessment of hemodynamic changes during the operation including heart rate, blood pressures for every 5 min till the end of surgery; (d) episodes of intraoperative hypotension treated by ephedrine in bolus dose of 5 mg (if mean arterial pressure <70 mmHg); and (e) episodes of intraoperative bradycardia treated by atropine in dose of 0.01 mg/kg (if heart rate <50 beat/min).
Randomization and blinding
During subarachnoid block to ensure the blinding, randomly allocated drug containing syringes were arranged and prepared by an anesthesiologist who did not achieve the subarachnoid block or record the intraoperative and postoperative period outcomes. The investigator and anesthesiologist achieving the study will be blinded to the type of the drugs contained in the syringes and the solution for all the three groups.
Statistical analysis
Data were assessed for normality using Shapiro-Wilk test and homogeneity using Bartlett's test for unequal variances. Relative frequencies and differences between categorical variables were calculated by using Fishers' exact test. Mean ± standard deviation and the mean differences between continuous variables were calculated using one-way ANOVA. [11] Tukey's tests were used to precisely determine where the difference in our means exist across all three groups and whether it is significant. Levels of statistical significance for all tests were set at 0.05. All analyses were conducted using the PROC ANOVA procedure in SAS ® software (version 9.4, SAS Institute, Cary, NC, USA).
Sample size of 20 patients for each group was determined in considering the mean duration of 130 ± 45 min for Group A in comparison with the possible duration of 180 ± 40 min for Group C and two-sided with the Cohen's effect size of 1.17 and 95 confidence interval through the G * Power 3.1.9 software (Heinrich, Heine University Dusseldorf; Germany). However, the sample size was extended to 30 for each group due to lost to follow up possibility.
results
The baseline characteristics of three study groups prior and intra-intervention commencement were compared in Table 1 . The mean age of Group A, B, and C were 28.00 ± 5.21, 29.00 ± 5.66, and 28.00 ± 5.34 years, respectively, fairly similar among all three groups. As shown in Table 1 , systolic blood pressure (SBP), diastolic blood pressure, and PR of patients in Groups A, B, and C were statistically comparable between groups before and during study intervention phases.
Deterioration of patients' hemodynamic status and the need for atropine and/or ephedrine were reported in Table 2 . Among all patients, 47 of them showed at least one episode of hypotension (SBP <70 mmHg) intraoperatively requiring a bolus of 5 mg ephedrine administration intravenously with no a substantial difference. In addition, two patients (6.67%) in Group B and three patients (10%) in Group C developed not <1 episode of bradycardia (PR < 50 bpm) requiring administration of 0.01 mg/kg of atropine intraoperatively, a statistically insignificant finding.
Duration of analgesia
The duration of motor block was longer significantly in the Group C received 12.5 mg bupivacaine + 2 mg midazolam (duration: 183.33 ± 32.77 min), compared to only 181 ± 47.66 min in the Group B received 12.5 mg bupivacaine + 1 mg midazolam and 138 ± 50.53 min in the Group A received only 12.5 mg bupivacaine (P < 0.0001), as shown in Table 3 .
Similarly, the duration of sensory block was significantly longer in the Group C with a mean duration of 212 ± 48.43 min, compared to 210 ± 51.14 min in Group B, and 142 ± 58.93 min in Group A (P < 0.0001), these differences were shown in Figures 1 and 2 .
Further statistical analyses showed that the anesthesia durations including motor and sensory block of Group C and B were statistically longer than their compartments in the patients of Group A. However, these differences were statistically significant between Groups B and C for motor and sensory block effects as the results of interventions.
dIscussIon
The authors' aim in conducting the current study was to evaluate the effect of 1 and 2 mg midazolam added to hyperbaric bupivacaine on the duration of motor and sensory block and intraoperative hemodynamic changes for CS under spinal anesthesia. The study showed that the aesthesia duration was statistically longer in those patients underwent 1 and 2 mg midazolam added to hyperbaric bupivacaine in comparison to the patients were underwent intrathecal bupivacaine 12.5 mg + 0.4 ml of normal saline and no substantial difference was found between Groups B and C. In addition, the no substantial differences of hemodynamic changes were found between three groups.
The effect of added midazolam to hyperbaric bupivacaine on longer analgesic duration in patients underwent regional anesthesia has been approved by other researchers across the world as well. For instance, Kim and Lee [12] randomly allocated 45 patients to three groups, including the control group (n = 15) received 1 ml of 0.5% heavy bupivacaine + 0.2 ml of 0.9% saline intrathecally, group BM1 (n = 15) received 1 ml of 0.5% bupivacaine + 0.2 ml (1 mg) of 0.5% preservative-free midazolam and group BM2 (n = 15) received 1 ml of 0.5% bupivacaine + 0.4 ml (2 mg) of 0.5% midazolam.
First time to rescue analgesic required by the patients was of great significance in the midazolam groups rather Probability > F = P value for the F test significant at a level of 0.05 than in the placebo and with less significance in the BM1 group than in the BM2 group with statistically insignificant difference in hemodynamic change among the 3 groups. Similarly, a meta-analysis confirmed that adding of 1 mg or 2 mg of subarachnoid midazolam will prolong the analgesic effect of bupivacaine postoperatively by approximately 2 h and 4.5 h, respectively, compared with controls group posthemorrhoidectomy advocating a dose-dependent action of subarachnoid midazolam.
However, we should put in our minds that pain of hemorrhoidectomy can be reduced only by blocks of sacral sensory nerves. In this study, patients underwent below umbilical obstetric surgeries, and for adequate analgesia, our patients required blockade of lumbar and lower thoracic dermatomes as well. The similar results were obtained by Batra et al. [13] without prolonging recovery among patients underwent knee arthroscopy. Even the longer analgesic duration was found by Chattopadhyay et al. [14] in patients underwent spinal analgesia for elective infraumbilical surgery, 320 min in adjuvant group versus 220 min in free midazolam group for sensory block and 255 min versus 195 min for motor block, respectively, and no substantial difference in side effects between both groups.
Shadangi et al. [15] allocated randomly 100 patients into two groups prepared for elective lower abdominal, lower limb, and gynecological procedures in a double-blind way for intrathecal drug administration. They showed the longer duration of sensory block in the midazolam group, 115.8 versus 90.8 min (P = 0.001), while in similar with our study, no significant difference was found in motor blockage, 151.3 versus 151.8 min (P = 0.051).
The current study was strength in successful randomly and double blind of patients into three study groups. However, the study was not exempt from the limitations. The results reported in the present study must be interpreted in the inherent of study design and take into account the stern exclusion criteria as we did not make a between-group comparison for the interventions side effects (except hemodynamic status) in patients underwent intrathecal bupivacaine 12.5 mg + 1 mg midazolam, and those underwent intrathecal bupivacaine 12.5 mg + 2 mg midazolam. However, it has been reported that 1 and 2 mg intrathecal midazolam is able to decrease postoperative nausea and vomiting, [16] or make do not significant change. [15] conclusIon It is concluded from this study that using of 1 mg midazolam + bupivacaine in comparison with 2 mg midazolam + bupivacaine have the same effect on duration of sensory and motor block with less side effects. Hence, we recommend using of 1 mg midazolam with bupivacaine instead of 2 mg to increase the duration of motor and sensory block during subarachnoid anesthesia for CS.
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